VRDN
Viridian Therapeutics Inc
$17.69
+0.34% (+$0.06)
Volume
1.53M
52W High
$34.29
52W Low
$13.18
Market Cap
$2.76B
Next Earnings Report
Last Reported
May 5, 2026 Beat
Actual: -$0.90
vs. Consensus: -$1.08
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 5, 2026
1-Day:
-6.51%
Q1 2026
Mar 31, 2026
1-Day:
-2.10%
Q4 2025
Mar 5, 2026
1-Day:
-1.90%
5-Day:
+1.04%
Q4 2025
Feb 26, 2026
1-Day:
-0.37%
5-Day:
-0.58%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $132,000 | +83.3% | -142.4% | -10,000.0% | -$120.4M |
| Q3'25 | $70.6M | +10,000.0% | 100.0% | -56.7% | -$34.6M |
| Q2'25 | $75,000 | +4.2% | 100.0% | -10,000.0% | -$100.7M |
| Q1'25 | $72,000 | +0.0% | 100.0% | -10,000.0% | -$86.9M |
| Q4'24 | $72,000 | +0.0% | 100.0% | -10,000.0% | -$79.7M |
| Q3'24 | $86,000 | +19.4% | 100.0% | -10,000.0% | -$76.7M |
| Q2'24 | $72,000 | +0.0% | 100.0% | -10,000.0% | -$65.0M |
| Q1'24 | $72,000 | -26.5% | 100.0% | -10,000.0% | -$48.5M |
Company Information
Symbol
VRDN
Company
Viridian Therapeutics Inc
Market Cap
$2.76B